Differential effects of pharmacological agents acting on monoaminergic systems on drug-induced anorexia.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001067:Appetite Depressants / Q000145:classification / Q000494:pharmacology*; D004285:Dogs; D018492:Dopamine Antagonists; D005277:Fenfluramine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D008711:Metergoline / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011903:Raphe Nuclei / Q000187:drug effects; D051381:Rats; D012702:Serotonin Antagonists / Q000494:pharmacology
D001067:Appetite Depressants; D018492:Dopamine Antagonists; D006892:Hydroxydopamines; D012702:Serotonin Antagonists; D008711:Metergoline; D005277:Fenfluramine; D000661:Amphetamine; D009638:Norepinephrine; D008784:Methysergide